Geron (GERN) Shares Outstanding (Weighted Average) (2010 - 2026)

Geron's (GERN) quarterly Shares Outstanding (Weighted Average) came in at $669375.0 in Q1 2026, up 0.52% year-on-year from $665905.0 in Q1 2025, and down 97.71% quarter-over-quarter from $29.3 million in Q4 2025.

Geron (GERN) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Geron has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $669375.0 for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $669375.0, up 0.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $669375.0 (up 0.52% YoY), and the FY2025 annual result was $29.3 million, down 95.47% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $669375.0 for Q1 2026 at Geron, down from $29.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $666.2 million in Q2 2025 to a low of $665905.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $332.1 million (2022), against an average of $265.5 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) tumbled 99.61% in 2024 and surged 30803.46% in 2025, its largest moves.
  • Geron's Shares Outstanding (Weighted Average) stood at $380.8 million in 2022, then soared by 49.86% to $570.6 million in 2023, then rose by 13.21% to $646.0 million in 2024, then sank by 95.47% to $29.3 million in 2025, then sank by 97.71% to $669375.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $669375.0 (Q1 2026), $29.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 185,491.37 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 417.01 Bn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 254.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - 928.40 Mn
10 Geron 753,046.88 753,046.88 - 669,375.00

Historic Data

Download Data
DateValue
Mar 31, 2026 669,375.00
Dec 31, 2025 29.29 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 666.17 Mn
Mar 31, 2025 665,905.00
Dec 31, 2024 646.03 Mn
Sep 30, 2024 2.15 Mn
Jun 30, 2024 2.16 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 570.65 Mn
Sep 30, 2023 2.47 Mn
Jun 30, 2023 547.28 Mn
Mar 31, 2023 544.46 Mn
Dec 31, 2022 380.78 Mn
Sep 30, 2022 380.66 Mn
Jun 30, 2022 403.87 Mn
Mar 31, 2022 332.07 Mn
Dec 31, 2021 327.63 Mn
Sep 30, 2021 326.55 Mn
Jun 30, 2021 325.34 Mn